Cargando…
Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity
Plasma cell responses are associated with anti-tumor immunity and favorable response to immunotherapy. B cells can amplify anti-tumor immune responses through antibody production; yet B cells in patients and tumor-bearing mice often fail to support this effector function. We identify dysregulated tr...
Autores principales: | Mirlekar, Bhalchandra, Wang, Yan, Li, Sirui, Zhou, Mi, Entwistle, Sarah, De Buysscher, Tristan, Morrison, Ashley, Herrera, Gabriela, Harris, Cameron, Vincent, Benjamin G., Ting, Jenny P.- Y., Rashid, Naim, Kim, William Y., Yeh, Jen Jen, Pylayeva-Gupta, Yuliya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512696/ https://www.ncbi.nlm.nih.gov/pubmed/36099917 http://dx.doi.org/10.1016/j.xcrm.2022.100744 |
Ejemplares similares
-
IL-12 Family Cytokines in Cancer and Immunotherapy
por: Mirlekar, Bhalchandra, et al.
Publicado: (2021) -
B Cell Receptor Signaling and Protein Kinase D2 Support Regulatory B Cell Function in Pancreatic Cancer
por: Michaud, Daniel, et al.
Publicado: (2022) -
Impact of IL-23 in prostate cancer
por: Mirlekar, Bhalchandra
Publicado: (2021) -
Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy
por: Mirlekar, Bhalchandra
Publicado: (2022) -
Chromatin Remodeling Protein SMAR1 Is a Critical Regulator of T Helper Cell Differentiation and Inflammatory Diseases
por: Mirlekar, Bhalchandra, et al.
Publicado: (2017)